These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 7757962

  • 1. The antiproliferative effect of vitamin D analogs on MCF-7 human breast cancer cells.
    Brenner RV, Shabahang M, Schumaker LM, Nauta RJ, Uskokovic MR, Evans SR, Buras RR.
    Cancer Lett; 1995 May 25; 92(1):77-82. PubMed ID: 7757962
    [Abstract] [Full Text] [Related]

  • 2. Growth inhibition of HT-29 human colon cancer cells by analogues of 1,25-dihydroxyvitamin D3.
    Shabahang M, Buras RR, Davoodi F, Schumaker LM, Nauta RJ, Uskokovic MR, Brenner RV, Evans SR.
    Cancer Res; 1994 Aug 01; 54(15):4057-64. PubMed ID: 8033137
    [Abstract] [Full Text] [Related]

  • 3. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
    Kubota T, Koshizuka K, Koike M, Uskokovic M, Miyoshi I, Koeffler HP.
    Cancer Res; 1998 Aug 01; 58(15):3370-5. PubMed ID: 9699668
    [Abstract] [Full Text] [Related]

  • 4. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
    Skowronski RJ, Peehl DM, Feldman D.
    Endocrinology; 1995 Jan 01; 136(1):20-6. PubMed ID: 7530193
    [Abstract] [Full Text] [Related]

  • 5. Growth inhibition of human colon adenocarcinoma-derived Caco-2 cells by 1,25-dihydroxyvitamin D3 and two synthetic analogs: relation to in vitro hypercalcemic potential.
    Cross HS, Farsoudi KH, Peterlik M.
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Jan 01; 347(1):105-10. PubMed ID: 8446178
    [Abstract] [Full Text] [Related]

  • 6. Phytoestrogen regulation of a Vitamin D3 receptor promoter and 1,25-dihydroxyvitamin D3 actions in human breast cancer cells.
    Wietzke JA, Welsh J.
    J Steroid Biochem Mol Biol; 2003 Feb 01; 84(2-3):149-57. PubMed ID: 12710998
    [Abstract] [Full Text] [Related]

  • 7. Enhancement of antiproliferative activity of 1alpha,25-dihydroxyvitamin D3 (analogs) by cytochrome P450 enzyme inhibitors is compound- and cell-type specific.
    Zhao J, Tan BK, Marcelis S, Verstuyf A, Bouillon R.
    J Steroid Biochem Mol Biol; 1996 Feb 01; 57(3-4):197-202. PubMed ID: 8645629
    [Abstract] [Full Text] [Related]

  • 8. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S, Krishnan AV, Feldman D.
    Clin Cancer Res; 2000 Aug 01; 6(8):3371-9. PubMed ID: 10955825
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of breast cancer cell growth by combined treatment with vitamin D3 analogues and tamoxifen.
    Vink-van Wijngaarden T, Pols HA, Buurman CJ, van den Bemd GJ, Dorssers LC, Birkenhäger JC, van Leeuwen JP.
    Cancer Res; 1994 Nov 01; 54(21):5711-7. PubMed ID: 7923220
    [Abstract] [Full Text] [Related]

  • 10. Differential regulation of normal and tumoral breast epithelial cell growth by fibroblasts and 1,25-dihydroxyvitamin D3.
    Gache C, Berthois Y, Cvitkovic E, Martin PM, Saez S.
    Breast Cancer Res Treat; 1999 May 01; 55(1):29-39. PubMed ID: 10472777
    [Abstract] [Full Text] [Related]

  • 11. Antiproliferative effect of 1,25-dihydroxyvitamin D3 and its analogs on human colon adenocarcinoma cells (CaCo-2): influence of extracellular calcium.
    Cross HS, Huber C, Peterlik M.
    Biochem Biophys Res Commun; 1991 Aug 30; 179(1):57-62. PubMed ID: 1883380
    [Abstract] [Full Text] [Related]

  • 12. 1alpha,25-Dihydroxyvitamin D3-3beta-(2)-bromoacetate, an affinity labeling derivative of 1alpha,25-dihydroxyvitamin D3 displays strong antiproliferative and cytotoxic behavior in prostate cancer cells.
    Swamy N, Persons KS, Chen TC, Ray R.
    J Cell Biochem; 2003 Aug 01; 89(5):909-16. PubMed ID: 12874825
    [Abstract] [Full Text] [Related]

  • 13. A novel vitamin D3 analog, 22-oxa-1,25-dihydroxyvitamin D3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia.
    Abe J, Nakano T, Nishii Y, Matsumoto T, Ogata E, Ikeda K.
    Endocrinology; 1991 Aug 01; 129(2):832-7. PubMed ID: 1855478
    [Abstract] [Full Text] [Related]

  • 14. Antiestrogen potentiation of antiproliferative effects of vitamin D3 analogues in breast cancer cells.
    Love-Schimenti CD, Gibson DF, Ratnam AV, Bikle DD.
    Cancer Res; 1996 Jun 15; 56(12):2789-94. PubMed ID: 8665515
    [Abstract] [Full Text] [Related]

  • 15. The effect of 1, 25-dihydroxyvitamin D3 on the growth of soft-tissue sarcoma cells as mediated by the vitamin D receptor.
    Shabahang M, Buffan AE, Nolla JM, Schumaker LM, Brenner RV, Buras RR, Nauta RJ, Evans SR.
    Ann Surg Oncol; 1996 Mar 15; 3(2):144-9. PubMed ID: 8646514
    [Abstract] [Full Text] [Related]

  • 16. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
    Verlinden L, Verstuyf A, Quack M, Van Camp M, Van Etten E, De Clercq P, Vandewalle M, Carlberg C, Bouillon R.
    J Bone Miner Res; 2001 Apr 15; 16(4):625-38. PubMed ID: 11315990
    [Abstract] [Full Text] [Related]

  • 17. Autocrine TGFbeta signaling mediates vitamin D3 analog-induced growth inhibition in breast cells.
    Yang L, Yang J, Venkateswarlu S, Ko T, Brattain MG.
    J Cell Physiol; 2001 Sep 15; 188(3):383-93. PubMed ID: 11473365
    [Abstract] [Full Text] [Related]

  • 18. Vitamin D receptors in breast cancer cells.
    Buras RR, Schumaker LM, Davoodi F, Brenner RV, Shabahang M, Nauta RJ, Evans SR.
    Breast Cancer Res Treat; 1994 Sep 15; 31(2-3):191-202. PubMed ID: 7881099
    [Abstract] [Full Text] [Related]

  • 19. Antiproliferative action of vitamin D-related compounds and insulin-like growth factor-binding protein 5 accumulation.
    Rozen F, Yang XF, Huynh H, Pollak M.
    J Natl Cancer Inst; 1997 May 07; 89(9):652-6. PubMed ID: 9150190
    [Abstract] [Full Text] [Related]

  • 20. Analysis of vitamin D analog-induced heterodimerization of vitamin D receptor with retinoid X receptor using the yeast two-hybrid system.
    Zhao XY, Eccleshall TR, Krishnan AV, Gross C, Feldman D.
    Mol Endocrinol; 1997 Mar 07; 11(3):366-78. PubMed ID: 9058382
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.